Hi All,
Kathrynne Holden used my name in reference to a past post on NMS...

Date:         Sat, 7 Aug 1999 08:08:19 -0700

Hi Friends,

Here are some URL's for those interested in learning more about NMS.

I "stole" the following paragraph from the first site listed, 'cuz it says
precisely what I wanted to say to preface these URL's.....

All medicines have side effects. But most medicines have more
benefits than side effects and the side effects can be controlled.
But the problem is doctors are often less than honest about the side
effects and consumers are uninformed about them. So when the
individual develops side effects they don't what to do or get scared
away from the medicine. On the other hand, if they were fully
informed beforehand, they would know just what to do when the effects
come. Following are articles on Neuroleptic Malignant Syndrome....

http://www.nami-nyc-metro.org/meds/sidefx.html

http://www.vh.org/Providers/Conferences/CPS/09.html

Knowledge can't hurt.............

Happy surfin' ............ murray

>>> Posting number 65470, dated 7 Aug 1999 09:06:41

Hi Friends,

Here is a little more on NMS.....

Title
Neuroleptic malignant syndrome. Recognition, prevention and
management.

Author
Velamoor VR

Address
London Health Science Centre, Ontario, Canada.

Source
Drug Saf, 19(1):73-82 1998 Jul Abstract

Neuroleptic malignant syndrome (NMS) is a rare but potentially lethal form
of drug-induced hyperthermia characterised by mental status changes,
muscle rigidity, hyperthermia and autonomic dysfunction. Increased
awareness and early recognition will lead to prompt management. The
diagnosis of NMS presents a challenge because several medical conditions
generate similar symptoms. The presentation and course of NMS can be quite
variable ranging from a stormy and potentially fatal course to a
relatively benign and self-limiting course. The most important aspect of
treatment is prevention. This includes reducing risk factors (e.g.
dehydration, agitation and exhaustion), early recognition of suspected
cases and prompt discontinuation of the offending agent. All patients with
psychosis should be monitored daily for dehydration and elevated
temperature, have vital signs checked and agitation should be watched for.
Antipsychotics should be used conservatively with gradual titration of
doses. The management of NMS should be based on a hierarchy of symptom
severity. Following an episode of NMS, the patient should be reassessed
for further treatment with antipsychotics and rechallenge should not be
attempted at least 2 weeks following resolution of symptoms of NMS. The
patient and family should be educated about the episode and consent for
further medication use obtained after a clear explanation of the
risk-benefit analysis.

amen.........murray

Hi Again,
Here are today's search results on NMS...

Neuroleptic Malignant Syndrome
http://www.nmsis.org/

NMS Hotline
http://www.nmsis.org/hotline.htm

DSM IV
http://www.behavenet.com/capsules/disorders/medindmovdis.htm

NEUROLOGIC MALIGNANT SYNDROME (NMS)
1959-1980
A CHRONOLOGICAL ANNOTATED  BIBLIOGRAPHY
prepared by John M. Friedberg, MD
February 5, 1997
http://www.idiom.com/~drjohn/biblio.html

NEUROLEPTIC MALIGNANT SYNDROME mini information sheet
http://www.ninds.nih.gov/patients/Disorder/neuroleptic-malignant/neuroleptic-malignant.htm

The International Coalition for Drug Awareness
What is Serotonin Syndrome?
http://www.drugawareness.org/serosyndrome.html

Drug Toxicity
http://www.ohsu.edu/cliniweb/C21/C21.613.276.html

Regards .............. murray
[log in to unmask]